Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2091626 | C1orf162 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 1 | - |
PV=1 FDR=1 FC=0.04 |
|
2091627 | C1orf162 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 1 | - |
PV=0.137 FDR=1 FC=-0.014 |
|
2091628 | EXOC5 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 14 | - |
PV=1 FDR=1 FC=-0.033 |
|
2091629 | MX1 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 21 | - |
PV=1 FDR=1 FC=0.055 |